Advertisement

Acta Parasitologica

, Volume 59, Issue 1, pp 25–30 | Cite as

Immunomodulation of ALT-2 and TLR may collude in antigen specific T cell hyporesponsiveness: Proposed mechanism for elevated IL-10 levels in Balb/C mice

  • Ramanathan Aparnaa
  • Perumal Kaliraj
Original Paper
  • 73 Downloads

Abstract

ALT-2, a novel antigen belonging to the chromadorea ALT-2 family of the filarial nematode is proved to clear filarial parasites in Jirds. In order to increase the protection efficacy by stimulating the cell mediated immunity, MPLA a detoxified derivative of LPS known to induce the cellular response, was used in this study as an adjuvant on mice models. ALT-2+MPLA formulation elicited a high titer of total IgG antibody, with profoundly increased levels of IgG2b. Reduced splenocyte proliferation was observed in immunized group when compared to control groups which could be attributed to many in vivo factors. The levels of IFN-γ were high in unstimulated MPLA group compared to ALT-2 stimulated MPLA group, suggesting that the ALT-2 antigen suppressed the IFN-γ levels. A high level of IL-10 was induced by the ALT-2+MPLA formulation, which inhibited the production of Th2 cytokines (IL-4, IL-5) and also reduced the Th1 cytokine (IFN-γ, IL-2) levels which are not in vogue with the classical MPLA adjuvant formulation. We propose a mechanism for this immunomodulation which involves a diminished expression of TLR-4, by which the filarial parasites have evolved to evade host immune mechanism.

Keywords

Filariasis ALT-2 MPLA TLR IL-10 immunomodulation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allen J.E., Lawrence R.A., Maizels R.M. 1996. APC from mice harbouring the filarial nematode, Brugia malayi, prevent cellular proliferation but not cytokine production. International Immunology, 8, 143–151.PubMedCrossRefGoogle Scholar
  2. Alvarez J.I. 2005. Inhibition of Toll Like Receptor immune responses by microbial pathogens. Front Biosci, 10, 582–587. DOI: 1554.PubMedCrossRefGoogle Scholar
  3. Babu S., Blauvelt C.P., Kumaraswami V., Nutman T.B. 2005. Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation. Journal of Immunology, 175, 1170–1176, DOI: 175/2/1170.Google Scholar
  4. Bomford R. 1980. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayedtype hypersensitivity in the mouse and guinea pig, and cellmediated immunity to tumour antigens in the mouse of Freund’s incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin. Clinical and Experimental Immunology, 39, 435–441.PubMedCentralPubMedGoogle Scholar
  5. Brattig N.W., Bazzocchi C., Kirschning C.J., Reiling N., Buttner D.W., Ceciliani F., et al. 2004. The major surface protein of Wolbachia endosymbionts in filarial nematodes elicits immune responses through TLR2 and TLR4. Journal of Immunology, 173, 437–445.Google Scholar
  6. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., Demengeot J. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. Journal of Experimental Medicine, 197, 403–411.PubMedCrossRefGoogle Scholar
  7. Casella C.R., Mitchell T.C. 2008. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cellular and Molecular Life Sciences, 65, 3231–3240. DOI: 10.1007/s00018-008-8228-6.PubMedCentralPubMedCrossRefGoogle Scholar
  8. Cottrez F., Hurst S.D., Coffman R.L. & Groux H. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. Journal of Immunology, 165, 4848–4853.Google Scholar
  9. Gnanasekar M., Rao K.V., He Y.X., Mishra P.K., Nutman T.B., Kaliraj P., et al. 2004. Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi. Infection and Immunity, 72, 4707–4715. DOI: 10.1128/IAI.72.8.4707-4715.2004.72/8/4707.PubMedCentralPubMedCrossRefGoogle Scholar
  10. Gregory W.F., Atmadja A.K., Allen J.E., Maizels R.M. 2000. The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis. Infection and Immunity, 68, 4174–4179.PubMedCentralPubMedCrossRefGoogle Scholar
  11. Hager D.A., Burgess R.R. (1980). Elution of proteins from sodium dodecyl sulfate-polyacrylamide gels, removal of sodium dodecyl sulfate, and renaturation of enzymatic activity: results with sigma subunit of Escherichia coli RNA polymerase, wheat germ DNA topoisomerase, and other enzymes. Analytical Biochemistry, 109, 76–86. DOI: 0003-2697(80)90013-5.PubMedCrossRefGoogle Scholar
  12. Hamaoka T., Katz D.H., Benacerraf B. 1973. Hapten-specific IgE antibody responses in mice. II. Cooperative interactions between adoptively transferred T and B lymphocytes in the development of IgE response. Journal of Experimental Medicine, 138, 538–556.PubMedCrossRefGoogle Scholar
  13. Harry R.A., Anderson A.E., Isaacs J.D., & Hilkens C.M. 2010. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Annals of the Rheumatic Diseases, 69, 2042–2050. DOI: ard.2009.126383.10.1136/ard.2009.126383.PubMedCentralPubMedCrossRefGoogle Scholar
  14. Hernandez I., Sanmartin O., Carda C., Gome S., Alfaro A. 2008. [B-cell pseudolymphoma caused by aluminium hydroxide following hyposensitization therapy]. Actas Dermosifiliogr, 99, 213–216. DOI:13116678.PubMedCrossRefGoogle Scholar
  15. Hori S., Nomura T., Sakaguchi S. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science, 299(5609), 1057–1061. DOI:10.1126/science.10794901079490.PubMedCrossRefGoogle Scholar
  16. Klaus G.G., Pepys M.B., Kitajima K., Askonas B.A. 1979. Activation of mouse complement by different classes of mouse antibody. Immunology, 38, 687–695.PubMedGoogle Scholar
  17. Kurniawan A., Yazdanbakhsh M., van Ree R., Aalberse R., Selkirk M.E., Partono F., et al. 1993. Differential expression of IgE and IgG4 specific antibody responses in asymptomatic and chronic human filariasis. Journal of Immunology, 150, 3941–3950.Google Scholar
  18. Maizels R.M., Allen J.E., Yazdanbakhsh M. 2000. Immunology of Lymphatic Filariasis: Current Controversies. In: Lymphatic Filariasis (Ed. Nutman T.B.). Imperial College Press, 217–243.CrossRefGoogle Scholar
  19. Maizels R.M., Balic A., Gomez-Escobar N., Nair M., Taylor M.D., Allen J.E. 2004. Helminth parasites-masters of regulation. Immunological Reviews, 201, 89–116. DOI: 10.1111/j.0105-2896.2004.00191.x. IMR191.PubMedCrossRefGoogle Scholar
  20. Maizels R.M., Holland M.J., Falcone F.H., Zang X.X., Yazdanbakhsh M. 1999. Vaccination against helminth parasites-the ultimate challenge for vaccinologists? Immunological Reviews, 171, 125–147.PubMedCrossRefGoogle Scholar
  21. Maizels R.M., Yazdanbakhsh M. 2003. Immune regulation by helminth parasites: cellular and molecular mechanisms. Nature Reviews Immunology, 3, 733–744. DOI: 10.1038/nri1183nri1183.PubMedCrossRefGoogle Scholar
  22. Neuberger M.S., Rajewsky K. 1981. Activation of mouse complement by monoclonal mouse antibodies. European Journal of Immunology, 11, 1012–1016, DOI: 10.1002/eji.1830111212.PubMedCrossRefGoogle Scholar
  23. Ottesen E.A., Weller P.F., Heck L. 1977. Specific cellular immune unresponsiveness in human filariasis. Immunology, 33, 413–421.PubMedGoogle Scholar
  24. Peter J. Delves, Seamus J. Martin, Dennis R. Burton & Roitt I.M. 2011. Roitt’s Essential Immunology (12th edition): Wiley-Blackwell.Google Scholar
  25. Porthouse K.H., Chirgwin S.R., Coleman S.U., Taylor H.W., Klei T.R. 2006. Inflammatory responses to migrating Brugia pahangi third-stage larvae. Infection and Immunity, 74, 2366–2372. DOI: 10.1128/IAI.74.4.2366-2372.2006.PubMedCentralPubMedCrossRefGoogle Scholar
  26. Ravichandran M., Mahanty S., Kumaraswami V., Nutman T.B., Jayaraman K. 1997. Elevated IL-10 mRNA expression and downregulation of Th1-type cytokines in microfilaraemic individuals with Wuchereria bancrofti infection. Parasite Immunology, 19, 69–77.PubMedCrossRefGoogle Scholar
  27. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., Levings M.K. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunological Reviews, 212, 28–50, DOI:IMR42010.1111/j.0105-2896.2006.00420.x.PubMedCrossRefGoogle Scholar
  28. Sharmila S., Christiana I., Kiran P., Reddy M.V., Kaliraj P. 2011. The adjuvant-free immunoprotection of recombinant filarial protein Abundant Larval Transcript-2 (ALT-2) in Mastomys coucha and the immunoprophylactic importance of its putative signal sequence. Experimental Parasitology, 129, 247–253. DOI: S0014-4894 (11)00241-410.1016/j.exppara.2011.08.005.PubMedCrossRefGoogle Scholar
  29. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., Kullberg B.J., et al. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. Journal of Clinical Investigation, 116, 485–494. DOI: 10.1172/JCI25439.PubMedCentralPubMedCrossRefGoogle Scholar
  30. Tomai M.A., Johnson A.G. 1989. T cell and interferon-gamma involvement in the adjuvant action of a detoxified endotoxin. Journal of Biological Response Modifiers, 8, 625–643.PubMedGoogle Scholar
  31. van Die I., Cummings R.D. 2006. Glycans modulate immune responses in helminth infections and allergy. Chemical Immunology and Allergy, 90, 91–112. DOI: 8888310.1159/000088883.PubMedGoogle Scholar

Copyright information

© Versita Warsaw and Springer-Verlag Wien 2014

Authors and Affiliations

  1. 1.Centre for BiotechnologyAnna UniversityChennaiIndia
  2. 2.Centre for BiotechnologyAnna UniversityGuindy, ChennaiIndia

Personalised recommendations